Literature DB >> 24764117

RTP801 regulates maneb- and mancozeb-induced cytotoxicity via NF-κB.

Shu-Yuan Cheng1, Seon Oh, Marcela Velasco, Christine Ta, Jessica Montalvo, Alyssa Calderone.   

Abstract

Environmental factors have been implicated in the pathogenesis of neurodegenerative diseases. Maneb (MB) and mancozeb (MZ) have been extensively used as pesticides. Exposure to MB lowers the threshold for dopaminergic damage triggered by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. MB and MZ potentiate 1-methyl-4-phenylpyridium (MPP(+))-induced cytotoxicity in rat pheochromocytoma (PC12) cells partially via nuclear factor kappa B (NF-κB) activation. RTP801 dramatically increased by oxidative stresses and DNA damage is the possible mechanism of neurotoxins-induced cell death in many studies. This study demonstrated that MB and MZ induced DNA damage as seen in comet assay. The expressions of RTP801 protein and mRNA were elevated after MB and MZ exposures. By knocking down RTP801 using shRNA, we demonstrated that NF-κB activation by MB and MZ was regulated by RTP801 and cell death triggered by MB and MZ was associated with RTP801 elevation. This revealed that the toxic mechanisms of dithiocarbamates are via the cross talk between RTP801 and NF-κB.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  NF-κB; RTP801; mancozeb; maneb

Mesh:

Substances:

Year:  2014        PMID: 24764117     DOI: 10.1002/jbt.21566

Source DB:  PubMed          Journal:  J Biochem Mol Toxicol        ISSN: 1095-6670            Impact factor:   3.642


  2 in total

1.  Involvement of Akt in mitomycin C and its analog triggered cytotoxicity in MCF-7 and K562 cancer cells.

Authors:  Shu-Yuan Cheng; Anayatzinc Vargas; Ji-Young Lee; Cristina C Clement; Elise Champeil
Journal:  Chem Biol Drug Des       Date:  2018-09-11       Impact factor: 2.817

Review 2.  RTP801/REDD1: a stress coping regulator that turns into a troublemaker in neurodegenerative disorders.

Authors:  Mercè Canal; Joan Romaní-Aumedes; Núria Martín-Flores; Víctor Pérez-Fernández; Cristina Malagelada
Journal:  Front Cell Neurosci       Date:  2014-10-02       Impact factor: 5.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.